VistaGen Says Data From Late-Stage Anxiety Study ‘Not Consistent’ With Prior Positive Phase 2 Study
VistaGen Therapeutics Inc (NASDAQ:VTGN) has announced topline results from its PALISADE-1 Phase 3 trial of PH94B for the acute treatment of…
EXCLUSIVE: Nisun Collaborates With Pinhutang Distillery To Boost China’s Agricultural Practices
NiSun Intl Enterprise Development Group Co, Ltd (NASDAQ: NISN) affiliate Fanlunke Supply Chain Management (Shanghai) Co, Ltd, a subsidiary of Fintech (Shanghai) Digital Technology Co, Ltd, forged a supply chain services agreement with Yunnan Pinh
Prominent British Sports Retailer JD Sports Sees Profits At Par With Last Year Thanks To Robust Demand
Leading British sportswear retailer JD Sports Fashion PLC (OTC:JDSPY) expects annual profit to be in line with last year’s performance…
Once A Cancer Company Silverback Merges With Small Biotech Working On Allergy Treatment
ARS Pharmaceuticals Inc will merge with Silverback Therapeutics Inc (NASDAQ:SBTX) in an all-stock transaction, with a new entity operating under the…
Liminal BioSciences Pulls Plug On Its Lead Development Program
Liminal BioSciences Inc (NASDAQ:LMNL) will discontinue the development of fezagepras based on results from the Phase 1a single ascending dose (SAD)…
3 Penny Stocks Insiders Are Buying: DiaMedica Therapeutics, Troika Media And More
U.S. stock futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Tesla, Danaher And Some Other Big Gainers From Yesterday
U.S. stocks closed higher on Thursday, with the Nasdaq Composite jumping around 1.4%. Here is the list of some big stocks recording gains in the previous session.
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
This Analyst Says Invitae’s Current Valuation ‘Not Accommodative’
Raymond James has downgraded Invitae Corp (NYSE:NVTA) to Market Perform from Outperform following news of a full reset, including leadership changes…